ICU Medical, Incorporated (NASDAQ:ICUI) Director Robert S. Swinney sold 229 shares of ICU Medical stock in a transaction that occurred on Friday, April 12th. The stock was sold at an average price of $231.43, for a total value of $52,997.47. Following the completion of the transaction, the director now directly owns 18,076 shares in the company, valued at $4,183,328.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
ICU Medical stock opened at $234.55 on Wednesday. The company has a market capitalization of $4.83 billion, a P/E ratio of 30.42 and a beta of 0.74. ICU Medical, Incorporated has a one year low of $210.94 and a one year high of $321.70.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, February 28th. The medical instruments supplier reported $1.78 EPS for the quarter, topping the Zacks’ consensus estimate of $1.56 by $0.22. The company had revenue of $340.38 million for the quarter, compared to analyst estimates of $314.60 million. ICU Medical had a return on equity of 13.31% and a net margin of 2.06%. Analysts predict that ICU Medical, Incorporated will post 8.58 EPS for the current year.
A number of equities analysts recently commented on ICUI shares. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, January 2nd. Raymond James cut their price objective on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a research note on Friday, March 1st. TheStreet lowered ICU Medical from a “b-” rating to a “c+” rating in a research note on Tuesday, March 19th. Finally, Zacks Investment Research lowered ICU Medical from a “hold” rating to a “sell” rating in a research note on Friday, January 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $281.00.
COPYRIGHT VIOLATION WARNING: “Insider Selling: ICU Medical, Incorporated (ICUI) Director Sells 229 Shares of Stock” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.com-unik.info/2019/04/17/insider-selling-icu-medical-incorporated-icui-director-sells-229-shares-of-stock.html.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: What are convertible shares?
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.